MerylLeboffMD
Endocrinology • Boston, MAOsteoporosis & Bone Metabolism Medicine, Parathyroid
Professor of Medicine, Brigham and Women's Hospital
Dr. Leboff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Brigham and Women's Hospital, Endocrinology, Diabetes and Hypertension Division, 221 Longwood Avenue, Boston, Mass
Boston, MA 02115Phone+1 617-732-6155Fax+1 617-732-5764
Summary
- I am an endocrinologist and Chief of the Calcium and Bone Section in the Division of Endocrinology, Diabetes and Hypertension at Brigham and Women’s Hospital (BWH). I am also Director of the Skeletal Health and Osteoporosis Center and Bone Density Unit, which I founded in 1987 after completion of my endocrinology fellowship at BWH. I am a Professor of Medicine at Harvard Medical School.
Education & Training
Brigham and Women's HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1979 - 1982
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1976 - 1979- University of Southern California/LACUSC Medical CenterInternship, Transitional Year, 1975 - 1976
Rutgers New Jersey Medical SchoolClass of 1975
Certifications & Licensure
MA State Medical License 1980 - 2025
NH State Medical License 2024 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Albert Nelson Marquis Lifetime Achievement Award Marquis Who's Who, 2019
- The Leading Physicians of the World The International Association of Healthcare Professionals, 2016, 2019
- Boston Magazine Castle Connolly, 2008, 2016-2019
- Join now to see all
Clinical Trials
- VITamin D and OmegA-3 TriaL (VITAL): Fractures, Vitamin D and Genetic Markers Start of enrollment: 2018 Jun 01
- VITamin D and OmegA-3 TriaL: Effects on Bone Structure and Architecture (VITAL) Start of enrollment: 2012 Aug 01
Publications & Presentations
PubMed
- 282 citationsAGA technical review on osteoporosis in gastrointestinal diseases.Charles N. Bernstein, William D. Leslie, Meryl S. LeBoff
Gastroenterology. 2003-03-01 - 220 citationsSerum 25-hydroxyvitamin D concentrations and risk for hip fractures.Jane A. Cauley, Andrea Z. LaCroix, Lieling Wu, Mara J. Horwitz, Michelle E. Danielson
Annals of Internal Medicine. 2008-08-19 - 793 citationsEffects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.Jane A. Cauley, John A Robbins, Zhao Chen, Steven R. Cummings, Rebecca D. Jackson
JAMA. 2003-10-01
Journal Articles
- Predicting Fracture Risk in Younger Postmenopausal Women: Comparison of the Garvan and FRAX Risk Calculators in the Women’s Health Initiative StudyErin S LeBlanc, Beatrice J Edwards, Kristine Ensrud, Meryl S LeBoff, Carolyn J Crandall, JoAnn E Manson, Journal of General Internal Medicine
- Bone Turnover Markers Are Not Associated with Hip Fracture Risk: A Case‐Control Study in the Women's Health InitiativeCarolyn J Crandall, Rebecca D Jackson, Meryl S LeBoff, Journal of Bone and Mineral Research
Press Mentions
Treating Fractures in Elderly Patients: Beyond the Broken BoneSeptember 6th, 2023
Osteoporosis vs. Osteoarthritis: What's the Difference?January 30th, 2020
No Bone Benefits Seen with High-Dose Vitamin D in Healthy CohortOctober 1st, 2019- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
